2022 - Research.com Best Female Scientist Award
2015 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2015 - Sedgwick Memorial Medal, American Public Health Association
Her primary areas of study are Alzheimer's disease, Neuroscience, Dementia, Disease and Cognition. Her Alzheimer's disease study integrates concerns from other disciplines, such as Biomarker, Neuroimaging and Cognitive decline. Her Dementia research is multidisciplinary, incorporating perspectives in Gerontology, Predictive value of tests, Imaging biomarker, Age of onset and Tauopathy.
Her Disease study combines topics in areas such as Psychiatry, Clinical trial and Intensive care medicine. Her research in Cognition intersects with topics in Alzheimer's disease biomarkers and Cohort study. Reisa A. Sperling combines subjects such as Placebo and Oncology with her study of Internal medicine.
Reisa A. Sperling mostly deals with Disease, Neuroscience, Internal medicine, Alzheimer's disease and Dementia. Her work in Disease addresses subjects such as Cognition, which are connected to disciplines such as Clinical psychology, Audiology and Developmental psychology. Her Neuroscience study which covers Amyloid that intersects with Positron emission tomography.
Her Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology. Her work carried out in the field of Alzheimer's disease brings together such families of science as Magnetic resonance imaging and Neuroimaging. Reisa A. Sperling works mostly in the field of Dementia, limiting it down to topics relating to Gerontology and, in certain cases, Activities of daily living, as a part of the same area of interest.
Her main research concerns Disease, Internal medicine, Cognitive decline, Cognition and Amyloid. Her Disease research is classified as research in Pathology. Her Dementia, Alzheimer's disease, Biomarker and Neurodegeneration investigations are all subjects of Internal medicine research.
Her work in Alzheimer's disease addresses issues such as Cohort study, which are connected to fields such as Depression. Reisa A. Sperling usually deals with Cognition and limits it to topics linked to Clinical trial and Odds ratio. As a part of the same scientific family, Reisa A. Sperling mostly works in the field of Amyloid, focusing on Neuroscience and, on occasion, Tauopathy.
The scientist’s investigation covers issues in Internal medicine, Alzheimer's disease, Cognition, Cognitive decline and Dementia. Her study in the field of Cohort, Apolipoprotein E and Pittsburgh compound B also crosses realms of Clinical neurology. Her Alzheimer's disease study is concerned with the larger field of Pathology.
Her Cognition study incorporates themes from Audiology, Disease, Family history and Depression. Her Cognitive decline research incorporates themes from Alzheimer's Disease Neuroimaging Initiative, Sex characteristics, Cardiology, Cognitive test and Amyloid. Her research in Dementia intersects with topics in Temporal lobe, Asymptomatic, Entorhinal cortex, Pediatrics and Tauopathy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease
Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan.
The New England Journal of Medicine (2012)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
Randy L. Buckner;Jorge Sepulcre;Tanveer Talukdar;Fenna M. Krienen.
The Journal of Neuroscience (2009)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack;Marilyn S. Albert;David S. Knopman;Guy M. McKhann.
Alzheimers & Dementia (2011)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow.
The New England Journal of Medicine (2014)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler.
Alzheimers & Dementia (2014)
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)
Amyloid deposition is associated with impaired default network function in older persons without dementia
Reisa A. Sperling;Reisa A. Sperling;Peter S. LaViolette;Kelly O'Keefe;Jacqueline O'Brien.
Neuron (2009)
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Bradford C. Dickerson;Akram Bakkour;David H. Salat;Eric Feczko.
Cerebral Cortex (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
Brigham and Women's Hospital
Brigham and Women's Hospital
Harvard University
Brigham and Women's Hospital
Harvard University
Brown University
University of Southern California
Stanford University
Harvard University
Washington State University
University of Helsinki
Iran University of Science and Technology
Forschungszentrum Jülich
Kyoto University
Shanghai University
University of Kent
University of Alberta
Ludwig-Maximilians-Universität München
University of Basel
Spaulding Rehabilitation Hospital
Indiana University
University of California, Riverside
Johns Hopkins University
Erasmus MC
University of London